ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Heartburn Drugs May Increase Heart Attack and Other Risks

Man holding medication cup

Popular drugs like Nexium, Prilosec and Aciphex used to provide relief from heartburn and acid reflux may increase the risk of heart attacks, according to a study by researchers at Stanford.

It’s one of many studies in recent years to reveal the drugs called proton pump inhibitors (PPIs) aren’t without risk. An April study by Canadian researchers linked PPIs to kidney failure.

“These drugs may not be as safe as we think,” Dr. Nicholas Leeper, the Stanford study’s senior author, said in a press release.

Are you suffering from complications after taking a PPI? Get a Free Case Review

The researchers looked at data in 16 million medical documents for 2.9 million people and found a 1.16-fold increased risk of myocardial infarction (heart attacks) in people who used proton pump inhibitors. They also found histamine H-2 blockers, like Zantac and Pepcid, did not increase the risk.

“The association we found with PPI use and increased chances of a subsequent heart attack doesn’t in and of itself prove causation,” the study’s lead author, Dr. Nigam Shah, pointed out in a press release.
The study published in PLOS One could not prove the drugs caused heart attacks, but the researchers were still alarmed by the results.

“We do think patients should think about their risks and benefits and should discuss their risk with their doctors,” Leeper told The Washington Post.

The market for medications to treat heartburn and acid reflux is massive. The prescription and over-the-counter (OTC) drugs brought in more than $13 billion in revenue in 2014, according to the study.

Types of Proton Pump Inhibitors

Drug Manufacturer Availability
Nexium (esomeprazole) AstraZeneca Prescription
AcipHex (rabeprazole) Eisai Prescription
Protonix (pantoprazole) Pfizer Prescription
Vimovo (esomeprazole magnesium and naproxen) Horizon Pharma Prescription
Dexilant (dexlansoprazole) Takeda Prescription
Prevacid (lansoprazole) Takeda Prescription and OTC
Prilosec (omeprazole) Procter and Gamble Prescription and OTC
Zegerid (omeprazole and sodium bicarbonate) Bayer and Salix Prescription and OTC

Doctors prescribe hundreds of millions of proton pump inhibitors every year, and even more are available over the counter, according to the study. The U.S. Food and Drug Administration warned the public about the dangers of long-term use of the heartburn drugs years ago, and researchers are continuing to learn about the potential dangers of the drug.

Proton Pump Inhibitors also Linked to Kidney Failure

In April, Canadian researchers published findings from a study involving more than 290,000 people above the age of 65 in Quebec who took PPIs in CMAJ Open, an online academic publication.

They found participants who took proton pump inhibitors were more than twice as likely to be hospitalized with kidney failure.

“Generally, the drugs are very well tolerated, and the vast majority of patients who take them will not develop (kidney failure) or other serious problems,” lead study author Dr. Tony Antoniou told MedPage Today. “But the drugs should be used for the shortest possible duration.”

Like the Stanford study investigating heart attack risks, the Canadian study could not prove the medications caused kidney failure. However, the authors of the study wrote doctors should be careful when prescribing the drugs, monitor patients and “discourage the indiscriminate use of these drugs.”

That means avoiding the drugs when symptoms subside or avoiding long-term use of the drug in many cases, something the FDA warned years ago.

A History of Severe Side Effects

Possible increased risks of heart attack and kidney failure are two of the most serious side effects of proton pump inhibitors. But PPIs can cause other harmful side effects.

As early as 2010, the FDA warned against long-term use of high dose proton pump inhibitor medications. The agency found evidence that long-term use could increase the risk of hip, wrist and spine fractures.

Two years later, the FDA warned PPIs could increase the risk of Clostridium difficile-associated diarrhea (CDAD). Clostridium difficile is a type of bacteria that causes major intestinal problems including diarrhea, fever, loss of appetite, nausea and abdominal pain. It’s usually associated with long-term use of antibiotics, and symptoms usually don’t improve on their own.

Other side effects of proton pump inhibitors include a risk of iron and Vitamin B12 deficiency, developing pneumonia, headaches, itching or nausea.

People usually use proton pump inhibitors to treat acid reflux, gastroesophageal disease (GERD) or heartburn. However, experts say many of those problems can be solved without the use of medications.

“In many cases, lifestyle modifications (e.g. avoiding precipitating foods, weight loss) may be all that are required,” Antoniou said.

Chris Elkins
Written By Chris Elkins Writer

Chris Elkins's expertise is in health communication. He worked with respected health communication scholar Athena du Pré on the textbook Communicating About Health: Current Issues and Perspectives: 5th Edition. He holds six certificates from the Centers for Disease Control and Prevention. Some of his qualifications include:

  • Graduate-level certificate in health communication leadership
  • Master's degree in strategic communication and leadership
  • Bachelor's degree in journalism

10 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. Antoniou, T., et al. (2015). Proton pump inhibitors and the risk of acute kidney injury in older patients: A population-based cohort study. CMAJ Open, 3(2), E166-E171. Retrieved from:
  2. Bernstein, L. (2015, June 10). Common heartburn medications linked to greater risk of heart attack. The Washington Post. Retrieved from:
  3. Brooks, M. (2015, August 13). 100 best-selling, most prescribed branded drugs through June. Medscape. Retrieved from:
  4. Rapaport, L. (2015, April 18). PPIs linked to kidney failure in seniors. MedPage Today. Retrieved from:
  5. Shah, N. H., et al. (2015). Proton pump inhibitor usage and the risk of myocardial infarction in the general population. PLOS One. Retrieved from:
  6. U.S. Food and Drug Administration. (2012, February 8). Proton pump inhibitors (PPIs) - Drug safety communication: Clostridium Difficile-Associated Diarrhea (CDAD) can be associated with stomach acid drugs [Press release]. Retrieved from:
  7. U.S. Food and Drug Administration. (2010, May 25). FDA: Possible fracture risk with high dose, long-term use of proton pump inhibitors. Retrieved from:
  8. U.S. National Library of Medicine. (2013). Proton pump inhibitors. Medline Plus. Retrieved from:
  9. U.S. National Library of Medicine. (2014). Clostridium difficile infections. Medline Plus. Retrieved from:
  10. Veterans Health Administration. (2015, June 24). Nexium delayed-release capsules 20mg, recall for containing Seroquel XR 150 mg tablets. Veterans Health Administration. Retrieved from:
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's trusted legal partners support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(866) 587-0279